Related references
Note: Only part of the references are listed.Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
Mariaelena Capone et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells
Ibrahim M. Sektioglu et al.
CANCER RESEARCH (2017)
Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy
Alvaro Moreira et al.
IMMUNOTHERAPY (2017)
S3-Guideline Diagnosis, Therapy and Follow-up of Melanoma- Update 2015/2016, Short Version 2.0
Thomas K. Eigentler et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2017)
Basal neutrophil-to-lymphocyte ratio is associated with overall survival in melanoma
Leonardo S. Lino-Silva et al.
MELANOMA RESEARCH (2017)
Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma
Jeremy L. Davis et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma
J. Zaragoza et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
P. F. Ferrucci et al.
ANNALS OF ONCOLOGY (2016)
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
Benjamin Weide et al.
CLINICAL CANCER RESEARCH (2016)
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens et al.
CLINICAL CANCER RESEARCH (2016)
Prognostic significance of hematological profiles in melanoma patients
Sara Gandini et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The Prognostic Role of the Preoperative Absolute Lymphocyte Count and Absolute Monocyte Count in Patients With Resected Advanced Melanoma
Nicole M. Rochet et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2015)
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients
P. F. Ferrucci et al.
BRITISH JOURNAL OF CANCER (2015)
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
Christoffer Gebhardt et al.
CLINICAL CANCER RESEARCH (2015)
Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells
Rafael Carretero et al.
NATURE IMMUNOLOGY (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Surgical Management of Intraabdominal Metastases From Melanoma: Role of the Neutrophil to Lymphocyte Ratio as a Potential Prognostic Factor
Ferdinando C. M. Cananzi et al.
WORLD JOURNAL OF SURGERY (2014)
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
J. Delyon et al.
ANNALS OF ONCOLOGY (2013)
The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer
Graeme J. K. Guthrie et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Lisa M. Coussens et al.
SCIENCE (2013)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Short-term morbidity associated with sentinel lymph node biopsy in cutaneous malignant melanoma
Adrian Ling et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2010)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Are Leukocytes and CRP Early Indicators for Anastomotic Leakage after Esophageal Resection?
S. Deitmar et al.
ZENTRALBLATT FUR CHIRURGIE (2009)
Persisting elevation of C-reactive protein after pancreatic resections can indicate developing inflammatory complications
Thilo Welsch et al.
SURGERY (2008)
Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer stage IV melanoma: Results of the EORTC 18951 Biochemotherapy Trial
Henrik Schmidt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model
H Schmidt et al.
BRITISH JOURNAL OF CANCER (2005)
Interlaboratory evaluation of a new reverse transcriptase polymerase chain reaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells:: A multicenter study of the dermatologic cooperative oncology group
U Reinhold et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors
TM Proebstle et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
